ERBB2 and ovarian cancer: Moreover, in a xenotransplant model for HER2+ ovarian cancer, adoptive transfer of autologous CD3+CD25− T cells and DCs loaded with HER2+ antigen results in T cell-mediated tumor regression, whereas concomitant transfer of Tregs blocks this antigen-specific immune response (66).